Podocyte dedifferentiation: A specialized process for a specialized cell

Frontiers in Endocrinology

Volumn 5, Issue OCT, 2014, Pages

  May, Carl James ^a   Saleem, Moin ^a   Welsh, Gavin Iain ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Dedifferentiation; Epithelial mesenchymal transition; Nephrotic syndrome; Podocytes; Proteinuria

Indexed keywords

ALPHA ACTININ 4; CD2 ASSOCIATED PROTEIN; F ACTIN; NEPHRIN; NERVE CELL ADHESION MOLECULE; P CADHERIN; PODOCIN; PROTEIN ZO1; TRANSCRIPTION FACTOR PAX2; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; WT1 PROTEIN;

CELL DEDIFFERENTIATION; CELL POLARITY; CELL STRUCTURE; EPITHELIAL MESENCHYMAL TRANSITION; GENE MUTATION; GLOMERULAR FILTRATION BARRIER; HUMAN; MESENCHYME CELL; NEPHROTIC SYNDROME; NONHUMAN; PATHOGENESIS; PODOCYTE; PROTEIN EXPRESSION; SHORT SURVEY; UPREGULATION;

EID: 84930636305     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2014.00148     Document Type: Short Survey

References (68)

1. Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol (2007) 2(3):529-42. doi: 10.2215/CJN.04121206
2. Sedor JR, Madhavan SM, Kim JH, Konieczkowski M. Out on a LIM: chronic kidney disease, podocyte phenotype and the Wilm's tumor interacting protein (WTIP). Trans Am Clin Climatol Assoc (2011) 122:184-97.
3. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol (2010) 21(2):212-22. doi:10.1681/ASN.2008121226
4. Lee HS. Mechanisms and consequences of TGF-ss overexpression by podocytes in progressive podocyte disease. Cell Tissue Res (2012) 347(1):129-40. doi:10.1007/s00441-011-1169-7
5. Yamaguchi Y, Iwano M, Suzuki D, Nakatani K, Kimura K, Harada K, et al. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy. Am J Kidney Dis (2009) 54(4):653-64. doi:10.1053/j.ajkd.2009.05.009
6. D'Agati VD, Kaskel FJ, Falk RJ. Focal segmental glomerulosclerosis. N Engl J Med (2011) 365(25):2398-411. doi:10.1056/NEJMra1106556
7. Ghiggeri GM, Gigante M, Di Donato A. Constitutional nephrin deficiency in conditionally immortalized human podocytes induced epithelial-mesenchymal transition, supported by beta-catenin/nf-kappa b activation: a consequence of cell junction impairment? Int J Nephrol (2013) 2013:457490. doi:10.1155/2013/457490
8. Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol (2008) 172(2):299-308. doi:10.2353/ajpath.2008.070057
9. Jefferson JA, Shankland SJ, Pichler RH. Proteinuria in diabetic kidney disease: a mechanistic viewpoint. Kidney Int (2008) 74(1):22-36. doi:10.1038/ki.2008.128
10. Samejima K, Nakatani K, Suzuki D, Asai O, Sakan H, Yoshimoto S, et al. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis. Nephron Clin Pract (2012) 120(1):c1-7. doi:10.1159/000334184
11. Faul C, Asanuma K, Yanagida-Asanuma E, Kim K, Mundel P. Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol (2007) 17(9):428-37. doi:10.1016/j.tcb.2007.06.006
12. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol (2002) 13(12):3005-15. doi:10.1097/01.ASN.0000039661.06947.FD
13. Tryggvason K. Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm. J Am Soc Nephrol (1999) 10(11):2440-5.
14. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev (2003) 83(1):253-307.
15. Gordon AM, Homsher E, Regnier M. Regulation of contraction in striated muscle. Physiol Rev (2000) 80(2):853-924.
16. Welsh GI, Saleem MA. The podocyte cytoskeleton-key to a functioning glomerulus in health and disease. Nat Rev Nephrol (2012) 8(1):14-21. doi:10.1038/nrneph.2011.151
17. Hildebrandt F. Genetic kidney diseases. Lancet (2010) 375(9722):1287-95. doi:10.1016/S0140-6736(10)60236-X
18. Brinkkoetter PT, Ising C, Benzing T. The role of the podocyte in albumin filtration. Nat Rev Nephrol (2013) 9(6):328-36. doi:10.1038/nrneph.2013.78
19. McCarthy HJ, Bierzynska A, Wherlock M, Ognjanovic M, Kerecuk L, Hegde S, et al. Simultaneous sequencing of 24 genes associated with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol (2013) 8(4):637-48. doi:10.2215/CJN.07200712
20. Nielsen R, Christensen EI. Proteinuria and events beyond the slit. Pediatr Nephrol (2010) 25(5):813-22. doi:10.1007/s00467-009-1381-9
21. Hutchison AS, O'Reilly DS, MacCuish AC. Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria. Clin Chem (1988) 34(10):2019-21.
22. Little MH, McMahon AP. Mammalian kidney development: principles, progress, and projections. Cold Spring Harb Perspect Biol (2012) 4(5). doi:10.1101/cshperspect.a008300
23. Takano K, Kawasaki Y, Imaizumi T, Matsuura H, Nozawa R, Tannji M, et al. Development of glomerular endothelial cells, podocytes and mesangial cells in the human fetus and infant. Tohoku J Exp Med (2007) 212(1):81-90. doi:10.1620/tjem.212.81
24. Kreidberg JA. Podocyte differentiation and glomerulogenesis. J Am Soc Nephrol (2003) 14(3):806-14. doi:10.1097/01.ASN.0000054887.42550.14
25. Reidy K, Susztak K. Epithelial-mesenchymal transition and podocyte loss in diabetic kidney disease. Am J Kidney Dis (2009) 54(4):590-3. doi:10.1053/j.ajkd.2009.07.003
26. Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard JB. The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech Dev (1993) 40(1-2):85-97. doi:10.1016/0925-4773(93)90090-K
27. Putaala H, Sainio K, Sariola H, Tryggvason K. Primary structure of mouse and rat nephrin cDNA and structure and expression of the mouse gene. J Am Soc Nephrol (2000) 11(6):991-1001.
28. Kawachi H, Koike H, Kurihara H, Yaoita E, Orikasa M, Shia MA, et al. Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. Kidney Int (2000) 57(5):1949-61. doi:10.1046/j.1523-1755.2000.00044.x
29. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, et al. NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet (2000) 24(4):349-54. doi:10.1038/74166
30. Li C, Ruotsalainen V, Tryggvason K, Shaw AS, Miner JH. CD2AP is expressed with nephrin in developing podocytes and is found widely in mature kidney and elsewhere. Am J Physiol Renal Physiol (2000) 279(4):F785-92.
31. Bottinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol (2002) 13(10):2600-10. doi:10.1097/01.ASN.0000033611.79556.AE
32. Chanan-Khan A, Miller KC, Musial L, Padmanabhan S, Yu J, Ailawadhi S, et al. Bortezomib in combination with pegylated liposomal doxorubicin and thalidomide is an effective steroid independent salvage regimen for patients with relapsed or refractory multiple myeloma: results of a phase II clinical trial. Leuk Lymphoma (2009) 50(7):1096-101. doi:10.1080/10428190902912460
33. Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A. TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell (2005) 16(4):1987-2002. doi:10.1091/mbc.E04-08-0658
34. Shankland SJ. The podocyte's response to injury: role in proteinuria and glomerulosclerosis. Kidney Int (2006) 69(12):2131-47. doi:10.1038/sj.ki.5000410
35. Zou J, Yaoita E, Watanabe Y, Yoshida Y, Nameta M, Li H, et al. Upregulation of nestin, vimentin, and desmin in rat podocytes in response to injury. Virchows Arch (2006) 448(4):485-92. doi:10.1007/s00428-005-0134-9
36. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 119(6):1420-8. doi:10.1172/JCI39104
37. Lv Z, Hu M, Zhen J, Lin J, Wang Q, Wang R. Rac1/PAK1 signaling promotes epithelial-mesenchymal transition of podocytes in vitro via triggering beta-catenin transcriptional activity under high glucose conditions. Int J Biochem Cell Biol (2013) 45(2):255-64. doi:10.1016/j.biocel.2012.11.003
38. Wang D, Dai C, Li Y, Liu Y. Canonical Wnt/beta-catenin signaling mediates transforming growth factor-beta1-driven podocyte injury and proteinuria. Kidney Int (2011) 80(11):1159-69. doi:10.1038/ki.2011.255
39. Herman-Edelstein M, Thomas MC, Thallas-Bonke V, Saleem M, Cooper ME, Kantharidis P. Dedifferentiation of immortalized human podocytes in response to transforming growth factor-beta: a model for diabetic podocytopathy. Diabetes (2011) 60(6):1779-88. doi:10.2337/db10-1110
40. Voulgari A, Pintzas A. Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta (2009) 1796(2):75-90. doi:10.1016/j.bbcan.2009.03.002
41. Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, Liu Y. Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol (2009) 20(9):1997-2008. doi:10.1681/ASN.2009010019
42. Saleem MA, Zavadil J, Bailly M, McGee K, Witherden IR, Pavenstadt H, et al. The molecular and functional phenotype of glomerular podocytes reveals key features of contractile smooth muscle cells. Am J Physiol Renal Physiol (2008) 295(4):F959-70. doi:10.1152/ajprenal.00559.2007
43. Kistler AD, Altintas MM, Reiser J. Podocyte GTPases regulate kidney filter dynamics. Kidney Int (2012) 81(11):1053-5. doi:10.1038/ki.2012.12
44. Harris JJ, McCarthy HJ, Ni L, Wherlock M, Kang H, Wetzels JF, et al. Active proteases in nephrotic plasma lead to a podocin-dependent phosphorylation of VASP in podocytes via protease activated receptor-1. J Pathol (2013) 229(5):660-71. doi:10.1002/path.4149
45. Lehtonen S, Lehtonen E, Kudlicka K, Holthöfer H, Farquhar MG. Nephrin forms a complex with adherens junction proteins and CASK in podocytes and in Madin-Darby canine kidney cells expressing nephrin. Am J Pathol (2004) 165(3):923-36. doi:10.1016/S0002-9440(10)63354-8
46. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol (2014) 15(3):178-96. doi:10.1038/nrm3758
47. Ransom RF, Lam NG, Hallett MA, Atkinson SJ, Smoyer WE. Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int (2005) 68(6):2473-83. doi:10.1111/j.1523-1755.2005.00723.x
48. Xing CY, Saleem MA, Coward RJ, Ni L, Witherden IR, Mathieson PW. Direct effects of dexamethasone on human podocytes. Kidney Int (2006) 70(6):1038-45. doi:10.1038/sj.ki.5001655
49. Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med (2008) 14(9):931-8. doi:10.1038/nm.1857
50. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, et al. WT-1 is required for early kidney development. Cell (1993) 74(4):679-91. doi:10.1016/0092-8674(93)90515-R
51. Patek CE, Fleming S, Miles CG, Bellamy CO, Ladomery M, Spraggon L, et al. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis. Hum Mol Genet (2003) 12(18):2379-94. doi:10.1093/hmg/ddg240
52. Ohtaka A, Ootaka T, Sato H, Soma J, Sato T, Saito T, et al. Significance of early phenotypic change of glomerular podocytes detected by Pax2 in primary focal segmental glomerulosclerosis. Am J Kidney Dis (2002) 39(3):475-85. doi:10.1053/ajkd.2002.31391
53. Qin XS, Tsukaguchi H, Shono A, Yamamoto A, Kurihara H, Doi T. Phosphorylation of nephrin triggers its internalization by raft-mediated endocytosis. J Am Soc Nephrol (2009) 20(12):2534-45. doi:10.1681/ASN.2009010011
54. Ruotsalainen V, Ljungberg P, Wartiovaara J, Lenkkeri U, Kestilä M, Jalanko H, et al. Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci U S A (1999) 96(14):7962-7. doi:10.1073/pnas.96.14.7962
55. Gerke P, Huber TB, Sellin L, Benzing T, Walz G. Homodimerization and heterodimerization of the glomerular podocyte proteins nephrin and NEPH1. J Am Soc Nephrol (2003) 14(4):918-26. doi:10.1097/01.ASN.0000057853.05686.89
56. Akhtar M, Al Mana H. Molecular basis of proteinuria. Adv Anat Pathol (2004) 11(6):304-9. doi:10.1097/01.pap.0000146219.03058.ea
57. Shih NY, Li J, Cotran R, Mundel P, Miner JH, Shaw AS. CD2AP localizes to the slit diaphragm and binds to nephrin via a novel C-terminal domain. Am J Pathol (2001) 159(6):2303-8. doi:10.1016/S0002-9440(10)63080-5
58. Salant J. Podocyte slit-diaphragm protein nephrin is linked to the actin cytoskeleton. Am J Physiol Renal Physiol (2002) 282(4):F585-91.
59. Caridi G, Perfumo F, Ghiggeri GM. NPHS2 (podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms. Pediatr Res (2005) 57(5 Pt 2):54R-61R. doi:10.1203/01.PDR.0000160446.01907.B1
60. Schwarz K, Simons M, Reiser J, Saleem MA, Faul C, Kriz W, et al. Podocin, a raft-associated component of the glomerular slit diaphragm, interacts with CD2AP and nephrin. J Clin Invest (2001) 108(11):1621-9. doi:10.1172/JCI200112849
61. Huber TB, Simons M, Hartleben B, Sernetz L, Schmidts M, Gundlach E, et al. Molecular basis of the functional podocin-nephrin complex: mutations in the NPHS2 gene disrupt nephrin targeting to lipid raft microdomains. Hum Mol Genet (2003) 12(24):3397-405. doi:10.1093/hmg/ddg360
62. Karle SM, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A. Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol (2002) 13(2):388-93.
63. Huber TB, Hartleben B, Kim J, Schmidts M, Schermer B, Keil A, et al. Nephrin and CD2AP associate with phosphoinositide 3-OH kinase and stimulate AKT-dependent signaling. Mol Cell Biol (2003) 23(14):4917-28. doi:10.1128/MCB.23.14.4917-4928.2003
64. Dustin ML, Olszowy MW, Holdorf AD, Li J, Bromley S, Desai N, et al. A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell (1998) 94(5):667-77. doi:10.1016/S0092-8674(00)81608-6
65. Welsch T, Endlich N, Kriz W, Endlich K. CD2AP and p130Cas localize to different F-actin structures in podocytes. Am J Physiol Renal Physiol (2001) 281(4):F769-77.
66. Coppo R. Different targets for treating focal segmental glomerular sclerosis. Contrib Nephrol (2013) 181:84-90. doi:10.1159/000348637
67. Lovatt D, Ruble BK, Lee J, Dueck H, Kim TK, Fisher S, et al. Transcriptome in vivo analysis (TIVA) of spatially defined single cells in live tissue. Nat Methods (2014) 11(2):190-6. doi:10.1038/nmeth.2804
68. Patrakka J, Lahdenkari AT, Koskimies O, Holmberg C, Wartiovaara J, Jalanko H. The number of podocyte slit diaphragms is decreased in minimal change nephrotic syndrome. Pediatr Res (2002) 52(3):349-55. doi:10.1203/00006450-200209000-00007